Treatment Action Group

TAGline Spring 2018: Bend the curves

Treatment Action Group releases the spring issue of TAGline, Bend the curves: Activism and the elimination of HIV, HCV, and TB.

Read More →

New guide to shorter regimen for treating drug-resistant TB

DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis

Read More →

Webinar: It’s Time to Deliver: Including Pregnant and Lactating Women in Clinical Research

The U.S. Division of AIDS (DAIDS) and its prevention and International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) networks have a long history of including pregnant and lactating women in clinical trials and of developing research agendas that target long standing and new knowledge gaps necessary to meet the needs of this neglected population.

Read More →

New guide: Your rights and TB care

An innovative and important new TB resource – Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide.

Read More →

Have your say! Survey on drug-resistant TB treatment options

In December 2017, Treatment Action Group (TAG), ACTION and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) conducted a webinar on the results of two phase III trials for treating rifampicin-resistant TB.

Read More →

Webinar: Prioritization of TB in 2018 PEPFAR COPs - webinar materials now available online

 

Read More →

Webinar: The results are in! Now what? - webinar materials now available online

The first ever phase III trials for multidrug-resistant TB (MDR-TB) finally yielded results. Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) presented the results in a webinar held on 12 December 2017. The webinar explored implications for the field, from the delamanid C213 trial and the STREAM trial to evaluate the shorter regimen for MDR-TB.

Read More →

TAG symposium: Reframing risk and accountability for action to ZERO TB - videos now available online

The symposium was held October 12 at the 2017 Union World Conference on Lung Health in Guadalajara, Mexico.

Read More →

Webinar: The results are in! Now what?

Exploring the implications of the delamanid phase III and STREAM trial results

Read More →

TAG releases new report on TB research funding

Higher funding for TB research signals hope, but governments must dramatically increase spending to end TB.

Read More →

Page 1 of 11 · Total posts: 10

1 2 Last→